EDAP TMS announced the presentation of positive final results from the Focal Ablation Versus Radical Prostatectomy (FARP) Study at the American Urological Association (AUA) Annual Meeting. This study is the first randomized controlled trial comparing ultrasound energy-based focal ablation versus Robotic Prostatectomy.
The FARP study achieved its primary endpoint, demonstrating that the rate of treatment failure in the Focal Ablation (FA) group was non-inferior to that in the Radical Prostatectomy (RP) group at the 36-month follow-up. The results showed a significantly lower rate of treatment failure in the focal ablation arm.
Focal One Robotic HIFU was used for the vast majority of patients treated with focal ablation in this study. These findings provide significant Level 1 evidence supporting the use of focal ablation with ultrasound energy for the management of organ-localized prostate cancer, which is expected to further accelerate Focal One adoption.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.